Biomarker analysis in advanced colorectal cancer patients treated with mFOLFOX6 plus bevacizumab or XELOX plus bevacizumab
收藏NIAID Data Ecosystem2026-03-08 收录
官方服务：
资源简介：
Interventions: mFOLFOX6 + Bevacizumab or XELOX + Bevacizumab Primary outcome(s): Correlation between plasma VEGF-A level and Progression free survival time in CRC patients Study Design: Single arm Non-randomized
创建时间：
2014-01-15
